Medinet Co., Ltd. operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medinet Co., Ltd. with three other
companies in this sector in Japan:
PhoenixBio Co Ltd
sales of 1.23 billion Japanese Yen [US$11.10 million]
Japan Tissue Engineering Company Limited
(2.14 billion Japanese Yen [US$19.28 million]
of which 96%
was Regenerative Medicine Products Business), and
Raqualia Pharma Incorporated
(1.42 billion Japanese Yen [US$12.82 million]
of which 100%
Medinet Co., Ltd. reported sales of ¥1.70 billion (US$15.39 million)
September of 2017.
decrease of 10.8%
versus 2016, when the company's sales were ¥1.91 billion.
Contributing to the drop in overall sales was the 95.5% decline
in Cell Therapy Products Business, from ¥32.60 million to ¥1.48 million.
There were also decreases in sales in
Cell Processing (down 9.3% to ¥1.70 billion)